The contribution of apolipoprotein E genetic variation to dementia risk in British South Asians
Open Access
- 17 April 2026
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 8 (3)
Abstract
Understanding the genetic basis of dementia in diverse populations is essential to ensure that efforts to predict, prevent, and treat dementia are equitable. The strongest genetic risk factor for dementia - APOE genotype - has not been assessed in population-scale cohorts of South Asian ancestry. To test whether APOE variation is associated with all-cause dementia in British South Asians, we analysed data from 51,104 volunteers Genes & Health study - a cohort study of British Bangladeshi and British Pakistani individuals who have undergone genotyping and consented for lifelong (England & Wales National Health Service) linkage to healthcare records. All-cause dementia was defined using electronic healthcare records. APOE genotypes were defined using phased, imputed genotype data. Cox proportional hazards models were used to assess the relationship between APOE genotype and dementia. Population attributable fractions were calculated for each APOE genotype. Phenome-wide association tests were performed to determine the impact of APOE genotype on a range of traits and disease. We identified 614 cases of dementia and 50,490 controls without any dementia diagnostic codes. Dementia cases (n = 614, of which 451 [73.5%] were incident) were recruited at an older age (median 71.3 vs 39.0), were more likely to be male (58.6% vs 44.5%), and were more likely to carry at least one APOE ε4 allele (26.4% vs 19.6%) than controls without dementia (n = 50,490). The APOE ε4 allele was associated with all-cause dementia in a dose-dependent fashion (APOE ε4/ε4: Hazard Ratio [HR] 2.7, 95% CI 1.7 - 4.2, P < 0.0001; APOE ε4/ε3: Hazard Ratio [HR] 1.5, 95% CI 1.2 - 1.8, P < 0.001; Cox multivariable regression models adjusted for age at recruitment, gender, genetic principal components 1 - 10, and genetic ancestry; all models used APOE ε3/ε3 as reference). The overall proportion of all-cause dementia cases which could be attributed to this allele was 12.9% (95% CI -5.9% - 25.5%). APOE ε4 was also associated with elevated triglycerides and Low Density Lipoprotein (LDL) cholesterol. APOE ε4 - the major genetic risk factor for sporadic dementia in European-ancestry populations - has a similar impact on dementia risk in British South Asians. Prediction and prevention studies aiming to use APOE to identify people at high risk of dementia should be inclusive of all ancestries. Genetic analysis of dementia risk in diverse populations is essential for ensuring that the downstream benefits - for prediction, prevention, and drug discovery - are shared equitably.Keywords
Funding Information
- Guarantors of Brain post-doctoral fellowship
- NIHR Clinical Lectureship
- National Institute for Health and Care Research (NIHR203373)
- Alzheimer’s Research UK
- London Network Centre Pump Prime
- Global Parkinson’s Genetics Program
- Aligning Science Across Parkinson's
- Michael J. Fox Foundation for Parkinson's Research
- Parkinson Research Foundation
This publication has 29 references indexed in Scilit:
- Impact of APOE4‐related dementia risk in underrepresented groups from the All of Us research programAlzheimer's & Dementia, 2025
- Effect of apolipoprotein E ε4 and its modification by sociodemographic characteristics on cognitive measures in South Asians from LASI‐DADAlzheimer's & Dementia, 2024
- The complex genetic architecture of Alzheimer's disease: novel insights and future directionsEBioMedicine, 2023
- Association of African Ancestry–Specific APOE Missense Variant R145C With Risk of Alzheimer DiseaseJAMA, 2023
- Incidence, age at diagnosis and survival with dementia across ethnic groups in England: A longitudinal study using electronic health recordsAlzheimer's & Dementia, 2022
- Apolipoprotein E (APOE) genotype-associated disease risks: a phenome-wide, registry-based, case-control study utilising the UK BiobankEBioMedicine, 2020
- Identifying dementia outcomes in UK Biobank: a validation study of primary care, hospital admissions and mortality dataEuropean Journal of Epidemiology, 2019
- Association of APOE polymorphisms and stressful life events with dementia in a Pakistani populationNeuroscience Letters, 2014
- Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE StatementHuman Genetics, 2009
- Apolipoprotein E Polymorphism and Alzheimer DiseaseArchives of Neurology, 2000